A review of multiple approaches towards an improved hepatitis B vaccine (Q37481243)

20 August 2017

1 reference

title

A review of multiple approaches towards an improved hepatitis B vaccine (English)

1 reference

20 August 2017

1 reference

Gautam Sanyal

1

1 reference

PubMed ID

19441898

20 August 2017

Li Shi

series ordinal

2

1 reference

PubMed ID

19441898

20 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

Expert Opinion on Therapeutic Patents

20 August 2017

1 reference

20 August 2017

19

1 reference

20 August 2017

1

1 reference

20 August 2017

59-72

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

20 August 2017

1 reference

Hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Natural history of hepatitis B virus infection: an update for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A review of hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Novel hepatitis B vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A hepatitis B vaccine formulated with a novel adjuvant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A prophylactic hepatitis B vaccine with a novel adjuvant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Peptide vaccines against hepatitis B virus: from animal model to human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Combined hepatitis B vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Factors important in the extraction, stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Reactogenicity profile of a combined hepatitis A and B vaccine in clinical practice: a naturalistic study in adult travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Development and production aspects of a recombinant yeast-derived hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770802587226

10.1517/13543770802587226

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19441898